This study, based on medical anthropology and oral reports, analyzes the meanings attributed by thalassemic adults to their experiences with the treatment. Interviews were used to collect data, which were analyzed through inductive thematic analysis. Eleven young adults, six of whom were men, at different ages, with different educational levels and occupations participated in the study. The meanings are discussed through the theme "the lives of patients with thalassemia in relation to their treatment". This core meaning highlights the difference made in their identity by having the disease trait, the recognition of the importance of adhering to their treatment, the difficulties in maintaining their social functions, the patients' irregular treatment adherence and their justifications for nonadherence to their treatment. Thalassemic patients conform to their condition and employ a normalization strategy to control the disease and justify irregular treatment adherence.
Introduction
Forms of thalassemia belong to a group of genetic diseases called hemoglobinopathies that compromise the normal production of chains of alpha and beta globins, which form hemoglobin. The incidence of thalassemia in Latin America and the Caribbean is heterogeneous, about 1% to 2% of the population. It was introduced by Portuguese, Spanish and Italian immigrants. The prevalence of thalassemia major, which is the most severe clinical form, is greater in the south and southeast of Brazil, affecting 1% of the population (1) .
Signs and symptoms of the disease emerge at the end of the first year of life and disappear with the diagnosis and beginning of treatment, and growth goes back to normal. If treatment is not initiated, the child may present severe general complications and die within the first or second decade of life (1) (2) .
Because of advanced knowledge concerning the disease and the effects of therapies, health professionals currently care for patients with thalassemia who have reached adult age. Treatments for thalassemia major include regular, lifetime, transfusions of red blood cells associated with iron chelation therapy. Although repetitive transfusions are a palliative therapy, it enables patients to develop normally, improve their quality of life and reach adult age (1) various organs. This accumulation leads to retardation of growth and sexual maturation, endocrine abnormalities, among other problems, although cardiac complications are more severe and account for 50% of deaths (3) .
There are three types of iron chelators employed in clinical practice: 1) Desferrioxamine (Desferal) must be subcutaneously or intravenously infused by pump at night on a regular basis: five or more times a week; 2)
Deferiprone was the first oral chelator to be licensed; its employed dose is divided into three daily doses; 3) Exjade (Deferasirox) is taken in a daily single dose via various effervescent tablets. These drugs have different actions on the various organs and their combined use may optimize the iron chelating effect without, however, increasing the intensity of side effects. The therapy has to be personalized to each patient according to each one's profile of iron overload and clinical condition (3) .
The use of oral chelators is recent. Patients using them follow a monthly medical monitoring regime due to resulting organic reactions and have their kidney functions and ferritin assessed (1) .
The interruption of transfusions and/or chelator infusions does not immediately induce symptoms.
Prolonged interruptions, though, worsen the patient's physical condition and iron concentration in different organs may increase, leading to an irreversible condition and death (1) .
For optimum adherence, the patient needs to attend a specialized service at least once a month for screening tests and a subsequent blood transfusion, introduce Desferal subcutaneously by infusion pump for eight hours daily, for a limited period, and/or ingest the appropriate dose of Deferiprone and/or Deferasirox.
Non-adhering patients with thalassemia major are reported by various authors (2) (3) and are a cause for concern. However, no Brazilian study addressing the 
The impact of thalassemia major and its treatments on the life of adult patients
A study addressing treatment adherence among 40 American individuals older than 18 years old showed that 37 of them used chelators through infusion; 77% of them had missed at least one dose in the previous month due to its side effects such as pain and irritation at the application site. The authors concluded that the chelator's side effects are responsible for non-adherence to treatment (4) .
The expectations of thalassemic individuals in relation to life composed the topic of a study involving 67 Greek patients aged between 18 and 45 years old.
Of these, 75% had a bachelor's degree, 71% worked, 67% had negative treatment adherence and 77.6%
had important complications. The results showed that pessimism in relation to the future was predominant among those with complications and lower levels of education; a better expectation in relation to life was observed among men (5) .
The hypothesis that the greater the knowledge one has in relation to a disease, the greater treatment adherence was investigated in a group of 32 patients, aged on average 17 years old. The results confirmed such a hypothesis: 43% had inaccurate knowledge of the disease and treatment and only 48% adhered to the therapeutic regime (6) .
Authors related educational level and occupation with other factors such as age, sexual and ethnical characteristics, therapeutic regime (transfusion and chelation) and clinical complications in a sample of 349
American and Canadian adults with thalassemia major.
The results indicated that 70% of adults were employed and 60% had an average educational level. Caucasian individuals worked in better-recognized professional activities; work was more frequent among older women without clinical complications. The authors concluded that neither transfusion nor chelation is a factor that hinders educational and professional development (7) .
One of the themes receiving more focus in studies is quality of life among thalassemic individuals in different age ranges. Unfortunately, these present contradictory results. One of these studies was of special interest because it included individuals from the same facility where this study was conducted and individuals presented similar social characteristics (8) . It involved 10 young adults aged between 22 and 28 years old through semi-structured interviews whose answers 971 www.eerp.usp.br/rlae Ganzella M, Zago MMF.
were analyzed according to content. Different scales were used to evaluate the participants' psychological conditions. The comparative analysis of the results on two points of the evaluation suggested that the quality of life of patients going into adult life was harmed and some presented increased psychological symptoms.
The experience of British young adults with thalassemia undergoing chelation therapy was the object of a socio-anthropological study (9) (10) . 
Theoretical and methodological framework
The theoretical structure of medical anthropology, the branch of the interpretative anthropology, which connects health, disease and culture was used in this study. Culture is seen as a system of meanings constructed in social life and shared with a group of which one is a part, providing parameters for how one thinks and acts. Medical anthropology views disease as a process characterized by the acknowledgement of its disorders, diagnosis, choice of treatment and evaluation. The disease and treatment are also experiences, because the body for the human being is a symbolic matrix that organizes one's experiences, relating them to the social, natural and cosmological worlds. Both disease and treatment generate bodily changes and these can be seen as a subjective reality where the body, perception, and meanings are united in a single interpretation (11) .
Medical anthropology distinguishes the constructions of 'disease' -the perspectives of biomedical objectivity and 'illness'-which is the patient's perspective, focused on subjectivity and includes the disease's cultural, social and personal elements (12) . For one to learn the similarities and differences among the perspectives of patients in the course of a chronic disease and treatment, one should explore the treatment's objectives, strategies, and evaluation criteria. Because explanations involve multiple and often contradictory processes and meanings, they are seen as situational explanations (13) . (14) .
Study procedures
The study was developed at the Hematology Center based on the participants' contexts of life, the theoretical framework and available literature (15) . The patients were ensured of their right to be informed about the study and freely consent to participate in it, as well as being ensured of the confidentiality of provided information and identity. Hence, fictitious names are used throughout the text to name the participants. Hence, the reports showed that the patients acknowledge the importance of maintaining regular treatment for their survival.
Data

Results
The patients reported experiences with social stigma given the disease and especially for having to periodically attend return visits and undergoing transfusions. 
Discussion
The reports show that being an adult with thalassemia major is a difficult experience due to the frequency of return medical visits, periodic transfusions, the daily use of medication, side effects caused by the transfusions and medications, and social stigma, that alter daily life, as revealed in the literature (4) (5) (6) (7) (8) .
The facility's professionals constantly inform the patients about the need to continue their treatment to ensure their survival, and these are aware of their "genetic trait" (being an individual with thalassemia). it (16) . Additionally, the way they approach their clinical conditions -my ferritin, and the use of medications -I'm using Exjade, are evidence of the fact that they have incorporated their disease and treatment (17) . That is, disease, treatment and body begin to constitute a single identity.
Symbolically, every person has an individual body (physical and psychological) that is acquired at birth and a social body that is necessary to live in a given cultural group. The social body is the essence of body image and self-image, because it provides a frame through which the person perceives and interprets physical and psychological experiences. It is also a means through which society controls behavior in disease and health, in working and leisure activities (18) . The idea that the sick body is a mediator of social relations has meaning in the case of chronic diseases given these diseases' In this context, treatment adherence is not a matter of practical difficulty; it symbolizes a threat to the normality of life -one of the processes through which power is manifested in the field of identity and difference; normalizing means attributing to identity all the possible positive characteristics, because a normal identity is desirable (19) .
The process of normalization as a strategy to cope with the disease is culturally learned and valued.
It enables one to deal with anguish, uncertainty and suffering, and is a common view of the chronic condition as shown in Brazilian papers addressing the experience of adult oncologic patients undergoing therapy (20) (21) .
When discussing the challenges associated with prolonging the survival of patients with thalassemia, from childhood to adulthood, authors (22) what matters most is to recognize that patients respond differently to therapies (23) .
We agree with a hematologist who says that even when there is success in maintaining chelation therapy, the patient is always between two polarized situations, that is, between the devil and the deep sea -toxicity by iron and toxicity by chelation. The patient does not directly feel the effects of iron excess or those of chelation; he can only imagine how harmful it can be to not regularly adhere to therapy (19) .
Hence, we see that therapy adherence is a process through which patients follow alternative paths that enable the feeling of satisfaction; s/he absorbs, analyzes, interprets, and reacts according to his/her knowledge, values and beliefs (culture), and decides whether to continue following a given treatment or not. Family and friends, rarely health professionals, help the patient with this decision. This influence demonstrates the power of the social network in one's decision-making process concerning care provided to health and disease (19) .
Final considerations
The thematic core indicates that the 11 young adults with thalassemia major, regardless of gender, 
